Effects of atypical antioxidative agents, S-nitrosoglutathione and manganese, on brain lipid peroxidation induced by iron leaking from tissue disruption

Annals of the New York Academy of Sciences

Volumn 899, Issue , 2000, Pages 238-254

  Rauhala, Pekka ^a,b   Chiueh, Chuang C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; 3 HYDROXYBENZYLHYDRAZINE; ANTIOXIDANT; ASCORBIC ACID; DEFEROXAMINE; EDETIC ACID; ESTRADIOL; FERRIC ION; FERROUS ION; FREE RADICAL; GLUTATHIONE; HEMOGLOBIN; HYDRALAZINE; IRON; IRON COMPLEX; MANGANESE; MELATONIN; N TERT BUTYL ALPHA PHENYLNITRONE; PENICILLAMINE; POLYUNSATURATED FATTY ACID; S NITROSOGLUTATHIONE; SELEGILINE; THIOCTIC ACID; TROLOX C;

BRAIN; BRAIN HOMOGENATE; CONFERENCE PAPER; FLUORESCENCE; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROPROTECTION; OXIDATIVE STRESS; TEMPERATURE;

EID: 0034078961     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06190.x     Document Type: Conference Paper

References (61)

1. 1. HALLIWELL, B. 1992. Reactive oxygen species and the central nervous system. J. Neurochem. 59: 1609-1623.
2. 2. AMES, B.N., M.K. SHIGENAGA & T.M. HAGEN. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90: 7915-7922.
3. 3. OLANOW, C.W. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci. 16: 439-444.
4. 4. CHIUEH, C.C., H. MIYAKE & M.T. PENG. 1993. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60: 251-258.
5. 5. SIMONIAN, N.A. & J.T. COYLE. 1996. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36: 83-106.
6. 6. SZIRAKI, I., P. RAUHALA, K.K. KOOH, P. VAN BERGEN & C.C. CHIUEH. 1999. Implications for atypical antioxidative properties of manganese in iron-induced lipid peroxidation and copper-dependent low density lipoprotein conjugation. Neurotoxicology, In press.
7. 7. QIAN, Y. & G.R. BUETTNER. 1996. Iron-oxygen complexes may be more important than the Fenton reaction in initiating biological free radical oxidations: an EPR spin trapping study. The 3rd annual meeting of the oxygen society. Abstract 1-82.
8. 8. HALL, E.D & J.M. BRAUGHLER. 1988. The role of oxygen radical-induced lipid peroxidation in acute central nervous system trauma. In Oxygen Radicals and Tissue Injury. B. Halliwell Ed. 92-98. FASEB, Bethesda.
9. 9. FLOYD, R.A. & J.M. CARNEY. 1992. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32: S22-S27.
10. 10. ESTERBAUER, H., R.J. SCHAUR & H. ZOLLNER. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11: 81-128.
11. 11. KRUMAN, L, A.J. BRUCE-KELLER, D. BREDESEN, G, WANG & M.P. MATTSON. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17: 5089-5100.
12. 12. DILLARD, C.J. & A.L. TAPPEL. 1973. Fluorescent products from reaction of peroxidizing polyunsaturated fatty acids with phosphatidyl ethanolamine and phenylalanine. Lipids 8: 183-189.
13. 13. SHIMASAKI, H. 1994. Assay of fluorescent lipid peroxidation products. Methods Enzymol. 233: 338-346.
14. 2+ injection. J. Neurochem. 42: 976-980.
15. 15. MOHANAKUMAR, K.P., A. DE BARTOLOMEIS, R.-M. WU, K.J. YEH, L. STERNBERGER, S.-Y. PENG, D.L. MURPHY & C.C. CHIUEH. 1994. Ferrous-citrate complex and nigral degeneration: Evidence for free-radical formation and lipid peroxidation. Ann. N.Y. Acad. Sci. 738: 392-399.
16. 16. RAUHALA, P., K.P. MOHANAKUMAR, I. SZIRAKI, A.M.-Y. LIN & C.C. CHIUEH. 1996. S-Nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23: 58-60.
17. 17. SZIRAKI, I., K.P. MOHANAKUMAR, P. RAUHALA, H.G. KIM, K.J. YEH & C.C. CHIUEH. 1998. Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism. Neuroscience 85: 1101-1111.
18. 2+ and ascorbic acid-stimulated lipid peroxidation in vitro. J. Neurochem. 34: 1630-1638.
19. + in vivo. Eur. J. Pharmacol. 243: 241-247.
20. 20. THE PARKINSON STUDY GROUP. 1993. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New Engl. J. Med. 328: 176-183.
21. 21. GOODMAN, Y., J.A. BRUCE, B. CHENG & M.P. MATTSON. 1996. Estrogens attenuates and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid -peptide toxicity in hippocampal neurons, J. Neurochem. 66: 1836-1844.
22. 22. GIUSTI, P., M. LIPARTITI, D. FRANCESCHINI, N. SCHIAVO, M. FLOREANI & H. MANEV. 1996. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10: 891-896.
23. 23. TANG, M.X., D. JACOBS, Y. STERN, K. MARDER, P. SCHOFIELD, B. GURLAND, H. ANDREWS & R. MAYEUX. 1996. Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348: 429-432.
24. 24. PAPPOLLA, M.A., M. SOS, R.A. OMAR, R.J. BICK, D.L. HICKSON-BICK, R.J. REITER, S. EFTHIMIOPOULOS & N.K. ROBAKIS. 1997. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17: 1683-1690.
25. 25. BEHL, C., T. SKUTELLA, F. LEZOUALCH, A. POST, M. WIDMANN, C.J. NEWTON & F. HOLSBOER. 1997. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51: 535-541.
26. 26. MYTILINEOU, C., P. RADCLIFFE, E.K. LEONARDI, P. WERNER & C.W. OLANOW. 1997. l-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro. J. Neurochem. 68: 33-39.
27. 27. SANO, M., C. ERNESTO, R.G. THOMAS, M.R. KLAUBER, K. SCHAFER, M. GRUNDMAN, P. WOODBURY, J. GROWDON, C.W. COTMAN, E. PFEIFFER, L.S. SCHNEIDER & L.J. THAL. 1997. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's diseases. N. Engl. J. Med. 336: 1216-1222.
28. 28. BIRGE, S.J. 1997. The role of estrogen in the treatment of Alzheimer's disease. Neurology 48: S36-S41.
29. 29. KIKUGAWA, K., T. KATO, M. BEBBU & A. HAYASAKA. 1989. A fluorescent and cross-linked proteins formed by free radicals and aldehyde species generated during lipid peroxidation. Adv. Exp. Med. Biol. 266: 345-356.
30. 30. HALLIWELL, B. & S. CHIRICO. 1993. Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 57(Suppl.): 715S-725S.
31. 31. RAUHALA, P., I. SZIRAKI & C.C. CHIUEH. 1996. Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals. Free Rad. Biol. Med. 21: 391-394.
32. 32. STOCKS, J., J.M.C. GUTTERIDGE, R.J. SHARP & T.L. DORMANDY. 1974. Assay using brain homogenates for measuring the antioxidant activity of biological fluids. Clin. Sci. Mol. Med. 47: 215-222.
33. 33. DEXTER, D.T., F.R. WELLS, A.J. LEES, F. AGID, Y. AGID, P. JENNER & C.D. MARSDEN. 1989. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseases. J. Neurochem. 52: 1830-1836.
34. 34. SOFIC, E., W. PAULUS, K. JELLINGER, P. RIEDERER & M.H.B. YOUDIM. 1991. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56: 978-982.
35. 35. CIUFFI, M., G. GENTILINI, S. FRANCHI-MICHELI & L. ZILETTI. 1992. D-Penicillamine affects lipid peroxidation and iron content in the rat brain cortex. Neurochem. Res. 17: 1241-1246.
36. 36. MILLER, D.M. & S.D. AUST. 1989. Studies of ascorbate-dependent, iron-catalyzed lipid peroxidation. Arch. Biochem. Biophys. 271: 113-119.
37. 37. HALL, E.D., J.M. BRAUGHLER, P.A. YONKERS, S.L. SMITH, K.L. LINSEMAN, E.D. MEANS, H.M., P.F. VON VOIGTLANDER, R.A. LAHTI & E.J. JACOBSEN. 1991. U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258: 688-694.
38. 38. NICKANDER, K.K., B.R. MCPHEE, P.A. Low & H. TRITSCHLER. 1996. α-Lipoic acid: antioxidant potency against lipid peroxidation of neural tissue in vitro and implications for diabetic neuropathy. Free Rad. Biol. Med. 21: 631-639.
39. + dopaminergic toxicity. J. Neural Transm. Gen. Sec. 100: 53-61.
40. 40. IACOVITTI, L., N.D. STULL & K. JOHNSTON. 1997. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res. 768: 317-326.
41. 41. CHIUEH, C.C., J.N. JOHANNESSEN, J.L. SUN, J.P. BACON & S.P. MARKEY. 1986. Reversible Neurotoxicity of MPTP in the nigrostriatal dopaminergic system of mice. In MPTP-Parkinsonian Syndrome Producing Neurotoxin. S.P. Markey, A.J. Trevor, N. Castagnoli & I.J. Kopin, Eds. :473-480. Academia Press, New York.
42. 42. GRIDLEY, K.E., P.S. GREEN & J.W. SIMPKINS 1997. Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778: 158-165.
43. 43. SHWAERY, G.T., J.A. VITA & J.F. KEANEY. 1997. Antioxidant protection of LDL by physiological concentrations of β-estradiol: requirement for estradiol modification. Circulation 95: 1378-1385.
44. 44. TATTON, W.G. & R.M.E. CHALMERS-REDMAN. 1996. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-Deprenyl-related compounds in controlling neurodegeneration. Neurology 47(Suppl.): S171-S183.
45. 45. ANTOLIN, I., C. RODRIGUEZ, R.M. SAINZ, J.C. MAYO, H. URIA, M.L. KOTLER, M.J. RODRIGUEZ-COLUNGA, D. TOLIVIA & A. MENENDEZ-PELAEZ. 1996. Neurohormone melatonin prevents cell damage: effects on gene expression for antioxidant enzymes. FASEB J. 10: 882-890.
46. 46. KANNER, J., L.S. HAREL & R. GRANIT. 1991. Nitric oxide as an antioxidant. Arch Biochem. Biophys. 289: 130-136.
47. 47. WINK, D.A., I. HANBAUER, M.C. KRISHNA, W. DEGRAFF, J. GAMSON & J.B. MITCHELL. 1993. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90: 9813-9817.
48. 48. HOGG, N., B. KALYANARAMAN, J. JOSEPH, A. STRUCK & S. PARTHASARATHY. 1993. Inhibition of low-density lipoprotein oxidation by nitric oxide, potential role in atherogenesis. FEBS Lett. 334: 170-174.
49. 49. RUBBO, H., R. RADI, M. TRUJILLO, R. TELLERI, B. KALYANARAMAN, S. BARNES, M. KIRK & B.A. FREEMAN. 1994. Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem. 269: 26066-26075.
50. 50. RAUHALA, P., A. M.-Y. LIN & C.C. CHIUEH. 1998. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12: 165-173.
51. 51. GASTON, B., J. REILLY, J.M. DRAZEN, J. FACKLER, P. RAMDEV, D. ARNELLE, M.E. MULLINS, D.J. SUGARBAKER, C. CHEE, D.J. SINGEL, J. LOSCALZO & J.S. STAMLER. 1993. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA 90: 10957-10961.
52. 52. KLUGE, I., U. GUTTECK-AMSLER, M. ZOLLINGER & K.Q. Do. 1997. S-Nitrosoglutathione in rat cerebellum: Identification and quantification by liquid chromatography-mass spectrometry. J. Neurochem. 69: 2599-2607.
53. 53. KIM, Y.-M., M.E. DE VERA, S.C. WATKINS & T.R. BILLIAR. 1997. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272: 1402-1411.
54. 54. WINK, D.A. & M. FEELISCH. 1996. Formation and detection of nitroxyl and nitrous oxide. In Methods in Nitric Oxide Research. M. Feelisch & J.S. Stamler, Eds. Vol. 1: 403-412. New York. John Wiley & Sons Ltd.
55. 55. RADI, R., J.S. BECKMAN, K.M. BUSH & B.A. FREEMAN. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
56. 56. LYMAR, S.V. & J.K. HURST. 1996. Carbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant. Chem. Res. Toxicol. 9: 845-850.
57. 57. PRYOR, W.A., J.N. LEMERCIER, H. ZHANG, R.M. UPPU & G.L. SQUADRITO. 1997. The catalytic role of carbon dioxide in the decomposition of peroxynitrite. Free Rad. Biol. Med. 23:331-338.
58. 58. FUKUTO, J.M., A.J. HOBBS & L.J. IGNARRO. 1993. Conversion of nitroxyl (HNO) to nitric oxide (NO·) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem. Biophys. Res. Commun. 196: 707-713.
59. 59. FUKUTO, J.M., K. CHIANG, R. HSZIEH, P. WONG & G. CHAUDHURI. 1992. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 263: 546-551.
60. 60. SCHMIDT, H.H.H., H. HOFMANN, U. SCHINDLER, Z.S. SHUTENKO, D.D. CUNNINGHAM & M. FEELISCH 1996. No NO from NO synthase. Proc. Natl. Acad. Sci. USA 93: 14492-14497.
61. 61. CHIUEH, C.C. & P. RAUHALA. 1999. The redox pathway of S-nitrosoglutathione, glutathione, and nitric oxide in cell to neuron communications. Free. Rad. Res. 31: 641-650.